Skip to content

Study on the protective effect of desflurane combined with propofol on the brain of patients with moyamoya disease undergoing cerebral revascularization

Study for the protective effect of desflurane on the brain of patients with moyamoya disease

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900027197
Enrollment
Unknown
Registered
2019-11-04
Start date
2019-05-01
Completion date
Unknown
Last updated
2022-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Moyamoya disease

Interventions

Group D:Desflurane for anesthesia maintenance
GroupP:Propofol
GroupPD:Desflurane and propofol

Sponsors

The First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 65 Years

Inclusion criteria

Inclusion criteria: Aged 20-65 years; BMI 18-25kg/m2; ASA I-II grade; patients without hypertension or with hypertension history and satisfactory blood pressure control; patients without diabetes or with diabetes history and satisfactory blood glucose control.Hemoglobin (HB) >= 100g / L, hematocrit (HCT) >= 30%; no coagulation dysfunction, no long-term history of antidepressant and analgesic drugs

Exclusion criteria

Exclusion criteria: Patient or his family refused to sign the informed consent form and patients with liver and kidney function abnormality, lung function abnormality, serious coronary heart disease, serious endocrine disease, mental disease, drug abuse, coagulation function abnormality, unconsciousness, organ intubation difficulty, and severe fluctuation of hemodynamics during operation.

Design outcomes

Primary

MeasureTime frame
Artefiovenous oxygen content difference;Cerebral oxygen extraction rate;Jugular venous blood oxygen saturation;Complication;GluERMB;LacPR;LOI;mRS score;NSE;S100ß protein;

Secondary

MeasureTime frame
Mean arterial pressure;

Countries

China

Contacts

Public ContactWang Zhongyu

The First Affiliated Hospital of Zhengzhou University

wzy781217@163.com+86 13937165514

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026